Daily News Podcast

Benzodiazepines double risk of suicide among COPD patients


 

Patients with chronic obstructive pulmonary disease who are taking benzodiazepines have more than double the risk of suicide compared with patients who are not on those medications. Also today, the feds say that the ACA’s silver plan premiums will drop in 2019, bias in the clinical setting can impact patient care, and managing asthma in children mean that pets do not always have to go.

The Postcall Podcast is available here: https://www.mdedge.com/podcasts

Recommended Reading

FDA approves new treatment for hereditary transthyretin-mediated amyloidosis
MDedge Internal Medicine
Allopurinol reduces risk of renal decline in gout patients
MDedge Internal Medicine
9-valent HPV vaccine approved for 27-45 age group
MDedge Internal Medicine
Outpatients antibiotics and disease codes
MDedge Internal Medicine
With more mindfulness, menopausal symptoms wane
MDedge Internal Medicine
Bisphosphonate holiday reduces risk of atypical femur fracture
MDedge Internal Medicine
Patient-centered guidelines for type 2 diabetes
MDedge Internal Medicine
NSAIDs’ short-term safety, IVUS beats angio, and more
MDedge Internal Medicine
Treating cryptococcal meningitis in patients with HIV
MDedge Internal Medicine
DOACs cut mortality
MDedge Internal Medicine